UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New drugs for non‐alcoholic steatohepatitis

Liver international, 2020-02, Vol.40 (S1), p.96-101

2020

Volltextzugriff (PDF)

Patients with uncertain advanced fibrosis and cirrhosis diagnosis by Agile3+ and Agile4 scores cannot be excluded in validation studies

Hepatology research, 2024-05, Vol.54 (5), p.495-496

2024

Volltextzugriff (PDF)

Relationship of ferritin and hepcidin with disease severity in non‐alcoholic fatty liver disease patients with type 2 diabetes mellitus

Liver international, 2023-11, Vol.43 (11), p.2571-2575

2023

Volltextzugriff (PDF)

Current management of NAFLD/NASH

Liver international, 2021-06, Vol.41 (S1), p.89-94

2021

Volltextzugriff (PDF)

Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study

Obesity (Silver Spring, Md.), 2024-06, Vol.32 (6), p.1210-1218

2024

Volltextzugriff (PDF)

Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A randomized, placebo‐controlled trial

Diabetes, obesity & metabolism, 2019-05, Vol.21 (5), p.1266-1270

2019

Volltextzugriff (PDF)

Acceptability and usability of oral fluid HCV self-testing for hepatitis C diagnosis: A systematic review and meta-analysis

Journal of viral hepatitis, 2023-11, Vol.30 (11), p.838-847

2023

Volltextzugriff (PDF)

Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

Liver international, 2009-01, Vol.29 (1), p.113-119

2009

Volltextzugriff (PDF)

Staging Fibrosis in Chronic Viral Hepatitis

Viruses, 2022-03, Vol.14 (4), p.660

2022

Volltextzugriff (PDF)

Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study

Cardiovascular diabetology, 2021-09, Vol.20 (1), p.193-193, Article 193

2021

Volltextzugriff (PDF)

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

Liver international, 2011-05, Vol.31 (5), p.700-706

2011

Volltextzugriff (PDF)

Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus

Liver international, 2024-04, Vol.44 (4), p.1042-1050

2024

Volltextzugriff (PDF)

NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?

International journal of molecular sciences, 2016-04, Vol.17 (4), p.460-460

2016

Volltextzugriff (PDF)

RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients

PloS one, 2016-04, Vol.11 (4), p.e0153796-e0153796

2016

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment

World journal of gastroenterology : WJG, 2014-07, Vol.20 (26), p.8377-8392

2014

Volltextzugriff (PDF)

Factors Associated with Disagreement of Fibrosis Stages between 2D-Shear Wave Elastography and Transient Elastography in Chronic Hepatitis B

Viruses, 2023-03, Vol.15 (4), p.846

2023

Volltextzugriff (PDF)

Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases

Annals of hepatology, 2021-05, Vol.22, p.100341-100341, Article 100341

2021

Volltextzugriff (PDF)

Liver Growth and Portal Hypertension Improvement After Percutaneous Recanalization of Chronic Portal Vein Thrombosis in Non-Cirrhotic Participants

Cardiovascular and interventional radiology, 2022-05, Vol.45 (5), p.582-589

2022

Volltextzugriff (PDF)

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study

The Brazilian journal of infectious diseases, 2022-09, Vol.26 (5), p.102697-102697, Article 102697

2022

Volltextzugriff (PDF)

Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study

Liver international, 2016-07, Vol.36 (7), p.977-985

2016

Volltextzugriff (PDF)

Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)

Annals of hepatology, 2019-05, Vol.18 (3), p.445-449

2019

Volltextzugriff (PDF)

Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver

Annals of hepatology, 2023-01, Vol.28 (1), p.100764-100764, Article 100764

2023

Volltextzugriff (PDF)

Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis

Annals of hepatology, 2020-01, Vol.19 (1), p.88-91

2020

Volltextzugriff (PDF)

Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study

Clinics (São Paulo, Brazil), 2021, Vol.76, p.e3236-e3236, Article e3236

2021

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(173)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

New drugs for non‐alcoholic steatohepatitis

Patients with uncertain advanced fibrosis and cirrhosis diagnosis by Agile3+ and Agile4 scores cannot be excluded in validation studies

Relationship of ferritin and hepcidin with disease severity in non‐alcoholic fatty liver disease patients with type 2 diabetes mellitus

Current management of NAFLD/NASH

Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study

Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A randomized, placebo‐controlled trial

Acceptability and usability of oral fluid HCV self-testing for hepatitis C diagnosis: A systematic review and meta-analysis

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis

Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

Staging Fibrosis in Chronic Viral Hepatitis

Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus

NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?

RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients

Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment

Factors Associated with Disagreement of Fibrosis Stages between 2D-Shear Wave Elastography and Transient Elastography in Chronic Hepatitis B

Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases

Liver Growth and Portal Hypertension Improvement After Percutaneous Recanalization of Chronic Portal Vein Thrombosis in Non-Cirrhotic Participants

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study

Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study

Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)

Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver

Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis

Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study

Suchergebnisse filtern